Martin Owsianowsky

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
T cell clones derived from a chronic myelogenous leukaemia (CML) patient during interferon alpha (IFN alpha, Wellferon) biotherapy preferentially lysed autologous rather than allogeneic CML target(More)
T cell clones derived from a chronic myelogenous leukaemia (CML) patient during interferon α (IFNα, Wellferon) biotherapy preferentially lysed autologous rather than allogeneic CML target cells in an(More)
  • 1